Delivery Order SPE2DB22D2006-SPE2DB24FV8GE

Award Date 2/20/24
Potential Completion Date 2/21/24
Potential Value $3.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Lyrica 75 mg capsules. The $12,389.87 order has a completion date of February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025...
This federal contract award, valued at $1,821.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lyrica 150 mg capsules in 90-count packages. This is a firm fixed-price delivery order contract with a completion date of January 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the delivery of Lyrica 150 mg capsules. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,075.80 and a completion date of September 18, 2024. The contract is not set aside for any specific program. AmerisourceBergen, a major pharmaceutical distributor, will supply the medication to support healthcare needs for military treatment facilities, veterans'...
This federal contract award, valued at $1,221.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lyrica 75 mg capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 6, 2025. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and there is no...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company. The contract, valued at $1,091.58, is for the delivery of Lyrica 75 mg capsules to support military treatment programs and facilities. The contract has an ultimate completion date of April 2, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. The company holds an...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of Lyrica 50 mg capsules. The contract, valued at $3,797.39, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical. It is a delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and facilities...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Lyrica 75 mg capsules. The contract has a potential value of $8,292.93 and a period of performance through March 7, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $3,454.21 firm fixed price delivery order is for the supply of Lyrica 75 mg capsules, a brand name prescription medication. The contract has a performance period that runs through March 6, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA worth up to...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,445.82 firm-fixed-price delivery order is for the supply of Lyrica 75 mg capsules, a medication used to treat certain types of nerve pain. The contract has a completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Lyrica 75 mg capsules. The contract has a ceiling value of $5,848.25 and is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of March 5, 2024 and was awarded on March 4, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds an...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FV8GE
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Lyrica 75 mg capsules in 90-count packages, with a firm fixed price of $3,232.14 and a completion date of February 21, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.

Generated 5/21/24, 11:15 AM